HHS Grants $2 Million for Vaccine Development Against Hepatitis C Virus
Grants
Copyright © Targeted News Service, 2025
Copyright © Targeted News Service, 2025
2025-09-25
Bailey Malota
WASHINGTON, Sept. 25 -- The U.S. Department of Health and Human Services, through the National Institutes of Health, has announced a funding opportunity aimed at advancing vaccine research for hepatitis C virus (HCV). The grant, titled Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed), provides an award ceiling of $2 million to support innovative approaches in vaccine development.
This funding will facilitate a consortium of Research Centers dedi . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Sept. 25 -- The U.S. Department of Health and Human Services, through the National Institutes of Health, has announced a funding opportunity aimed at advancing vaccine research for hepatitis C virus (HCV). The grant, titled Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed), provides an award ceiling of $2 million to support innovative approaches in vaccine development.
This funding will facilitate a consortium of Research Centers dedi . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com